GSK Investigational Site

Pearland, Texas 77584

2 studies enrolling now · 4 studies all time

What they study most

Diabetes Mellitus, Type 2, Irritable Bowel Syndrome, Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease

Studies at this site

• A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH — Recruiting now
• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) — Recruiting now
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. — Completed
• Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only — Completed